Drug Shortage Report for ACT METHYLPHENIDATE ER

Last updated on 2020-03-05 History
Report ID 65999
Drug Identification Number 02441969
Brand name ACT METHYLPHENIDATE ER
Common or Proper name METHYLPHENIDATE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 54MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-03-30
Actual start date
Estimated end date 2020-04-30
Actual end date
Shortage status Actual shortage
Updated date 2020-03-05
Company comments Inventory will be managed and allocated for 100% of regular demand. Estimated run out late March 2019
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-03-05 French Compare
v20 2020-03-05 English Compare
v19 2020-01-09 French Compare
v18 2020-01-09 English Compare
v17 2019-11-07 French Compare
v16 2019-11-07 English Compare
v15 2019-10-31 French Compare
v14 2019-10-31 English Compare
v13 2019-10-24 French Compare
v12 2019-10-24 English Compare
v11 2019-10-17 French Compare
v10 2019-10-17 English Compare
v9 2019-10-10 French Compare
v8 2019-10-10 English Compare
v7 2019-10-10 French Compare
v6 2019-10-10 English Compare
v5 2019-08-22 French Compare
v4 2019-08-22 English Compare
v3 2019-03-31 English Compare
v2 2018-11-01 French Compare

Showing 1 to 20 of 21